BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36799165)

  • 1. Zinc finger protein‑like 1 is a novel neuroendocrine biomarker for prostate cancer.
    Masud N; Aldahish A; Iczkowski KA; Kale A; Shah GV
    Int J Oncol; 2023 Mar; 62(3):. PubMed ID: 36799165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RING domain of zinc finger protein like 1 is essential for cell proliferation in endometrial cancer cell line RL95-2.
    Cai MJ; Zhan FX; Kong XN; Zhu SZ; Cui Y; Wang Q
    Gene; 2018 Nov; 677():17-23. PubMed ID: 30036656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of ZFPL1 results in increased autophagy and autophagy‑related cell death in NCI‑N87 and BGC‑823 human gastric carcinoma cell lines.
    Xie YZ; Ma WL; Meng JM; Ren XQ
    Mol Med Rep; 2017 May; 15(5):2633-2642. PubMed ID: 28447717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZFPL1, a novel ring finger protein required for cis-Golgi integrity and efficient ER-to-Golgi transport.
    Chiu CF; Ghanekar Y; Frost L; Diao A; Morrison D; McKenzie E; Lowe M
    EMBO J; 2008 Apr; 27(7):934-47. PubMed ID: 18323775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells.
    Moritz T; Venz S; Junker H; Kreuz S; Walther R; Zimmermann U
    Tumour Biol; 2016 Aug; 37(8):10435-46. PubMed ID: 26846108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway.
    Cortés MA; Cariaga-Martinez AE; Lobo MV; Martín Orozco RM; Motiño O; Rodríguez-Ubreva FJ; Angulo J; López-Ruiz P; Colás B
    Carcinogenesis; 2012 Jun; 33(6):1169-77. PubMed ID: 22461520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen Receptor Signaling Pathways Involved in Invasion and Colony Formation of Androgen-Independent Prostate Cancer Cells PC-3.
    Lombardi APG; Cavalheiro RP; Porto CS; Vicente CM
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.
    Banudevi S; Senthilkumar K; Sharmila G; Arunkumar R; Vijayababu MR; Arunakaran J
    Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state.
    Kwon W; Choi SK; Kim D; Kim HG; Park JK; Han JE; Cho GJ; Yun S; Yu W; Han SH; Ha YS; Lee JN; Kwon TG; Cho DH; Yi JK; Kim MO; Ryoo ZY; Park S
    J Exp Clin Cancer Res; 2021 Sep; 40(1):291. PubMed ID: 34537073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation.
    Jongsma J; Oomen MH; Noordzij MA; Van Weerden WM; Martens GJ; van der Kwast TH; Schröder FH; van Steenbrugge GJ
    Cancer Res; 2000 Feb; 60(3):741-8. PubMed ID: 10676662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A-kinase anchoring protein 2 is required for calcitonin-mediated invasion of cancer cells.
    Thakkar A; Aljameeli A; Thomas S; Shah GV
    Endocr Relat Cancer; 2016 Jan; 23(1):1-14. PubMed ID: 26432469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin induces stem cell-like phenotype in prostate cancer cells.
    Aldahish A; Kale A; Aljameeli A; Shah GV
    Endocr Relat Cancer; 2019 Nov; 26(11):815-828. PubMed ID: 31561211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.
    Morell C; Bort A; Vara D; Ramos-Torres A; Rodríguez-Henche N; Díaz-Laviada I
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):248-57. PubMed ID: 27324222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.
    Mabjeesh NJ; Willard MT; Frederickson CE; Zhong H; Simons JW
    Clin Cancer Res; 2003 Jul; 9(7):2416-25. PubMed ID: 12855613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin is a prostate epithelium-derived growth stimulatory peptide.
    Chien J; Ren Y; Qing Wang Y; Bordelon W; Thompson E; Davis R; Rayford W; Shah G
    Mol Cell Endocrinol; 2001 Jul; 181(1-2):69-79. PubMed ID: 11476942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action.
    Sabbisetti VS; Chirugupati S; Thomas S; Vaidya KS; Reardon D; Chiriva-Internati M; Iczkowski KA; Shah GV
    Int J Cancer; 2005 Nov; 117(4):551-60. PubMed ID: 15929083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THBS4 silencing regulates the cancer stem cell-like properties in prostate cancer via blocking the PI3K/Akt pathway.
    Hou Y; Li H; Huo W
    Prostate; 2020 Jul; 80(10):753-763. PubMed ID: 32421868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt.
    Martín-Orozco RM; Almaraz-Pro C; Rodríguez-Ubreva FJ; Cortés MA; Ropero S; Colomer R; López-Ruiz P; Colás B
    Neoplasia; 2007 Aug; 9(8):614-24. PubMed ID: 17898861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin induces apoptosis resistance in prostate cancer cell lines against cytotoxic drugs via the Akt/survivin pathway.
    Thomas S; Shah G
    Cancer Biol Ther; 2005 Nov; 4(11):1226-33. PubMed ID: 16222118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
    Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA
    Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.